Watch Cardiology Grand Rounds from The Texas Heart Institute on September 12, 2025. Dr. Michael Reardon presents “Current TAVR Data and the Lifetime Management of Aortic Stenosis”
Returning to Texas Heart Institute, Dr. Michael Reardon discusses TAVR and aortic stenosis management, highlighting the importance of understanding conflicts of interest in clinical trials. They review various TAVR trials and their outcomes, noting advancements in valve technology. The analysis shows no significant difference in valve dysfunction between TAVR and traditional surgery, emphasizing the need for structural validation. The future of TAVR looks promising, especially for younger patients.

Register for our upcoming symposia: https://www.texasheart.org/our-symposia